Dong Zhou

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 12

Top Venues

International journal of molecular sciences

Journal of labelled compounds & radiopharmaceuticals

ACS medicinal chemistry letters

Biomedicines

Washington University in Saint Louis School of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Washington University in Saint Louis School of Medicine

United States

Instructor :: Radiology

Publications

Dong Zhou, Wenhua Chu, Huaping Chen, Jinbin Xu
Exploration of Directing-Group-Assisted, Copper-Mediated Radiofluorination and Radiosynthesis of [ 18 F]Olaparib. ACS medicinal chemistry letters 15 (1) (2023)
Dong Zhou, Wenhua Chu, Jinbin Xu
A practical protocol for large-scale copper-mediated radioiodination of organoboronic precursors: Radiosynthesis of [ 123 I]KX-1 for Auger radiotherapy. Journal of labelled compounds & radiopharmaceuticals (2023)
Sreeja Sreekumar, Dong Zhou, Cedric Mpoy, Elsa Schenk, Jalen Scott, Jeffrey M Arbeit, Jinbin Xu, Buck E Rogers
Preclinical Efficacy of a PARP-1 Targeted Auger-Emitting Radionuclide in Prostate Cancer. International journal of molecular sciences 24 (4) (2023)
Sreeja Sreekumar, Dong Zhou, Cedric Mpoy, Elsa Schenk, Jalen Scott, Jeffrey M Arbeit, Jinbin Xu, Buck E Rogers
Preclinical Efficacy of a PARP-1 Targeted Auger-Emitting Radionuclide in Prostate Cancer. International journal of molecular sciences 24 (4) (2023)
Sreeja Sreekumar, Dong Zhou, Cedric Mpoy, Elsa Schenk, Jalen Scott, Jeffrey M Arbeit, Jinbin Xu, Buck E Rogers
Preclinical Efficacy of a PARP-1 Targeted Auger-Emitting Radionuclide in Prostate Cancer. International journal of molecular sciences 24 (4) (2023)
Sreeja Sreekumar, Dong Zhou, Cedric Mpoy, Elsa Schenk, Jalen Scott, Jeffrey M Arbeit, Jinbin Xu, Buck E Rogers
Preclinical Efficacy of a PARP-1 Targeted Auger-Emitting Radionuclide in Prostate Cancer. International journal of molecular sciences 24 (4) (2023)
Dong Zhou, Wenhua Chu, Huaping Chen, Jinbin Xu
Exploration of Directing-Group-Assisted, Copper-Mediated Radiofluorination and Radiosynthesis of [ 18 F]Olaparib. ACS medicinal chemistry letters 15 (1) (2023)
Leonard C Rogers, Jeff C Kremer, Caitlyn B Brashears, Zongtao Lin, Zhixian Sherrie Hu, Alliny Cristiny da Silva Bastos, Adriana Baker, Nicole Fettig, Dong Zhou, Kooresh I Shoghi, Carina A Dehner, John S A Chrisinger, John S Bomalaski, Benjamin A Garcia, Toshinao Oyama, Eileen P White, Brian Andrew Van Tine
Discovery and targeting of a noncanonical mechanism of sarcoma resistance to ADI-PEG20 mediated by the microenvironment. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Dong Zhou, Wenhua Chu, Huaping Chen, Jinbin Xu
Exploration of Directing-Group-Assisted, Copper-Mediated Radiofluorination and Radiosynthesis of [ 18 F]Olaparib. ACS medicinal chemistry letters 15 (1) (2023)
Dong Zhou, Huaping Chen, Cedric Mpoy, Sadia Afrin, Buck E Rogers, Joel R Garbow, John A Katzenellenbogen, Jinbin Xu
Radiosynthesis and Evaluation of Talazoparib and Its Derivatives as PARP-1-Targeting Agents. Biomedicines 9 (5) (2021)
Dong Zhou, Wenhua Chu, John A Katzenellenbogen
Exploration of alcohol-enhanced Cu-mediated radiofluorination toward practical labeling. Journal of labelled compounds & radiopharmaceuticals (2021)
Dong Zhou, Sung Hoon Kim, Wenhua Chu, Thomas Voller, John A Katzenellenbogen
Evaluation of aromatic radiobromination by nucleophilic substitution using diaryliodonium salt precursors. Journal of labelled compounds & radiopharmaceuticals 60 (9) (2017)

Dong Zhou.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Dong Zhou